相关实验视频

Updated: Jun 2, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

针对高风险急性髓性白血病的精密疗法

Abdur Jamil¹, Zaheer Qureshi², Zain Mary El-Amir³

¹Department of Medicine, Samaritan Medical Centre Watertown, NY, USA.

Leukemia research reports

|January 15, 2025

概括

作为一种新型脑膜抑制剂的revumenib在治疗具有特定基因突变的急性髓性白血病 (AML) 方面表现有前途. 需要进一步的试验来确定其作为高风险AML的标准治疗方法的作用.

科学领域:

在瘤学瘤学.
血液学血液学血液学
分子生物学分子生物学

背景情况:

急性髓性白血病 (AML) 仍然是一个重大挑战,特别是具有KMT2A重组或NPM1突变的子集.
针对性治疗对于改善这些高风险AML患者的治疗结果至关重要.

研究的目的:

审查目前关于Revumenib的证据,这是一种第一类的脑膜抑制剂,用于治疗AML.
突出Revumenib在基因定义的AML中的潜力及其对未来治疗策略的影响.

主要方法:

本小小的综述综合了现有的临床数据和关于Revumenib的临床前证据.
专注于其在相关AML模型和患者群体中的作用机制和疗效.

主要成果:

雷文尼布选择性地破坏了由KMT2A重组或NPM1突变驱动的关键白血病发生途径.
早期证据表明,Revumenib在这些特定的AML亚型中具有临床前景.

结论:

雷明尼布代表了一种有前途的向疗法,用于AML的不同亚组.
目前正在进行的临床试验对于确定最佳使用,安全性和潜在的组合来确定Revumenib作为标准护理至关重要.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.在 KMT2A 中.门抑制疗法是男性的抑制疗法.这就是Revumenib.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...